Revenue: The sum of all revenue fields included for a company's operating activities.
Pasithea Therapeutics Corp. (KTTA) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
-- |
$-13.90M |
|
-- |
|
-- |
|
$14.25M |
|
$-14.25M |
|
$0.35M |
|
$-13.90M |
|
$-13.90M |
|
$-13.90M |
|
$-13.90M |
|
$-13.90M |
|
$-13.90M |
|
$-14.25M |
|
$-13.60M |
|
1.10M |
|
1.10M |
|
$-12.69 |
|
$-12.69 |
|
Balance Sheet Financials | |
$7.37M |
|
$0.12M |
|
$8.70M |
|
$16.06M |
|
$1.12M |
|
-- |
|
$0.16M |
|
$1.28M |
|
$14.78M |
|
$6.21M |
|
$14.78M |
|
1.39M |
|
Cash Flow Statement Financials | |
$-13.92M |
|
-- |
|
$4.52M |
|
$16.33M |
|
$6.92M |
|
$-9.41M |
|
$0.77M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
6.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-94.06% |
|
-223.96% |
|
-86.55% |
|
-94.06% |
|
$10.60 |
|
$-12.70 |
|
$-12.70 |